 Sulfasalazine treatment juvenile chronic arthritis open study open study effect sulfasalazine treatment juvenile chronic arthritis JCA patients boys girls JCA years age study treatment nonsteroidal antiinflammatory drugs NSAID unable disease patients subgroups mode onset evolution Type systemic onset Type II polyarticular form Type IIIa Type IIIb pauciarticular form Remission patients significant improvement Status unchanged patients patients side effects interruption treatment Sulfasalazine patients toxicity inefficacy patients treatment prolonged remission promising results double blind versus placebo study III JCA